Host expression of methylmalonyl-CoA mutase and tuberculosis: a missing link?
José de la Fuente1, Christian Gortazar, Joaquín Vicente
1Instituto de Investigación en Recursos Cinegéticos IREC (CSIC-UCLM-JCCM), Ronda de Toledo s/n, 13005 Ciudad Real, Spain. jose_delafuente@yahoo.com
Medical Hypotheses
|November 19, 2010
Summary
Higher methylmalonyl-CoA mutase (MUT) expression in hosts may lower cholesterol, boosting immunity against bovine tuberculosis (bTB). This could improve BCG vaccine response and bTB resistance in livestock and humans.
Area of Science:
- Veterinary Immunology
- Infectious Diseases
- Host-Pathogen Interactions
Background:
- Bovine tuberculosis (bTB), caused by Mycobacterium bovis, affects livestock, wildlife, and humans.
- Variable BCG vaccination response and low active TB incidence despite high infection rates suggest underlying host factors.
- Existing hypotheses on genetic factors, environmental mycobacteria, and metabolism haven't linked host genetics to metabolic processes influencing bTB outcomes.
Purpose of the Study:
- To propose a hypothesis linking host genetic factors, specifically methylmalonyl-CoA mutase (MUT) expression, to cholesterol metabolism and its impact on Mycobacterium bovis infection and BCG vaccination response.
- To explore the role of host cholesterol in modulating the immune response to M. bovis infection.
Main Methods:
- Review of published data on host cholesterol metabolism in mycobacterial infections.
- Analysis of M. bovis infection and BCG vaccination studies in the wild boar bTB model.
- Formulation of a hypothesis based on integrated data.
Main Results:
- Proposed hypothesis: Higher host MUT expression leads to lower serum cholesterol and tissue deposits.
- This metabolic state is hypothesized to enhance the protective immune response against M. bovis.
- The proposed mechanism suggests increased resistance to bTB and improved BCG vaccination efficacy.
Conclusions:
- Host genetically-defined cholesterol metabolism may play a crucial role in bTB susceptibility and vaccine response.
- This hypothesis provides a novel link between host genetics, metabolism, and mycobacterial disease outcome.
- Further research is needed to validate this hypothesis and explore its therapeutic and preventative implications for bTB in humans and animals.
Related Concept Videos
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...


